88 related articles for article (PubMed ID: 3498181)
1. The osteodystrophy of hypervitaminosis D: a metabolic study.
Davies M; Mawer EB; Freemont AJ
Q J Med; 1986 Oct; 61(234):911-9. PubMed ID: 3498181
[TBL] [Abstract][Full Text] [Related]
2. Treatment with high-dose oral vitamin D2 in patients with jejunoileal bypass for morbid obesity. Effects on calcium and magnesium metabolism, vitamin D metabolites, and faecal lag time.
Charles P; Mosekilde L; Søndergård K; Jensen FT
Scand J Gastroenterol; 1984 Nov; 19(8):1031-8. PubMed ID: 6335925
[TBL] [Abstract][Full Text] [Related]
3. The vitamin D endocrine system, calcium metabolism, and osteoporosis.
Slovik DM
Spec Top Endocrinol Metab; 1983; 5():83-148. PubMed ID: 6367121
[TBL] [Abstract][Full Text] [Related]
4. Treatment of osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy.
Hoikka V; Savolainen K; Karjalainen P; Alhava EM; Sivenius J
Ann Clin Res; 1982 Apr; 14(2):72-5. PubMed ID: 6983324
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic osteomalacia after jejunoileal bypass surgery in a patient with primary hyperparathyroidism. A study of the change in bone morphology and vitamin D metabolites before and during treatment.
Taylor HC; Teitelbaum SL; Lambert PW
Gastroenterology; 1983 Sep; 85(3):735-42. PubMed ID: 6603388
[TBL] [Abstract][Full Text] [Related]
6. An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D.
Zerwekh JE; Glass K; Jowsey J; Pak CY
J Clin Endocrinol Metab; 1979 Aug; 49(2):171-5. PubMed ID: 313402
[TBL] [Abstract][Full Text] [Related]
7. Mineral and bone metabolism in thyroid disease: a review.
Auwerx J; Bouillon R
Q J Med; 1986 Aug; 60(232):737-52. PubMed ID: 3774957
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic osteomalacia associated with a mesenchymal chondrosarcoma.
Stone E; Bernier V; Rabinovich S; From GL
Clin Invest Med; 1984; 7(3):179-85. PubMed ID: 6518684
[TBL] [Abstract][Full Text] [Related]
9. Effect of correction of metabolic acidosis on bone mineralisation rates in patients with renal osteomalacia.
Cochran M; Wilkinson R
Nephron; 1975; 15(2):98-110. PubMed ID: 239358
[TBL] [Abstract][Full Text] [Related]
10. Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.
Kaplan MM; Goldberg MJ; Matloff DS; Neer RM; Goodman DB
Gastroenterology; 1981 Oct; 81(4):681-5. PubMed ID: 6973499
[TBL] [Abstract][Full Text] [Related]
11. [Serum concentrations of 1,25-dihydroxyvitamin D in cases of osteomalacia, parathyroid dysfunction and idiopathic hypercalciuria].
Audran M; Renier JC; Jallet P; Bidet M; Basle MF; Seret P
Rev Rhum Mal Osteoartic; 1987 Feb; 54(2):163-9. PubMed ID: 3563383
[TBL] [Abstract][Full Text] [Related]
12. Fractional calcium absorption is increased in girls with Rett syndrome.
Motil KJ; Schultz RJ; Abrams S; Ellis KJ; Glaze DG
J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):419-26. PubMed ID: 16641581
[TBL] [Abstract][Full Text] [Related]
13. [Vitamin D and collagen of bone tissue (review)].
Spirichev VB; Isaeva VA
Vopr Med Khim; 1984; 30(2):5-17. PubMed ID: 6377686
[No Abstract] [Full Text] [Related]
14. Endocrine and bone consequences of cyclic nutritional changes in the calcium, phosphate and vitamin D status in the rat: an in vivo depletion-repletion-redepletion study.
Mailhot G; Petit JL; Dion N; Deschênes C; Ste-Marie LG; Gascon-Barré M
Bone; 2007 Sep; 41(3):422-36. PubMed ID: 17617234
[TBL] [Abstract][Full Text] [Related]
15. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.
Bikle DD
Rheum Dis Clin North Am; 1994 Aug; 20(3):759-75. PubMed ID: 7984788
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D metabolism, rickets, and osteomalacia.
Berry JL; Davies M; Mee AP
Semin Musculoskelet Radiol; 2002 Sep; 6(3):173-82. PubMed ID: 12541194
[TBL] [Abstract][Full Text] [Related]
17. Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry.
Bisballe S; Eriksen EF; Melsen F; Mosekilde L; Sørensen OH; Hessov I
Gut; 1991 Nov; 32(11):1303-7. PubMed ID: 1752460
[TBL] [Abstract][Full Text] [Related]
18. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
Jones G; Hogan DB; Yendt E; Hanley DA
CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
[TBL] [Abstract][Full Text] [Related]
19. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.
Salusky IB; Goodman WG; Sahney S; Gales B; Perilloux A; Wang HJ; Elashoff RM; Jüppner H
J Am Soc Nephrol; 2005 Aug; 16(8):2501-8. PubMed ID: 15944337
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D physiology.
Lips P
Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
